title: Factors associated with the fecal occult blood testing for colorectal cancer screening based on health belief model structures in moderate risk individuals, Isfahan, 2011.
abstract: BACKGROUND
  Colorectal cancer is one of the most important and most common cancers and the second leading cause of cancer deaths worldwide. Every year, nearly 1 million new cases of colorectal cancer are recognized around the world and nearly half of them lose their lives due to the disease. The statistics reveal shocking incidence and mortality from colorectal cancer, therefore secondary prevention of this cancer is important and research has shown that by early diagnosis 90% of patients can be treated. Among the colorectal cancer screening tests, fecal occult blood test (FOBT) takes the priority because of its convenience and also low cost. But due to various reasons, the participation of people in this screening test is low. The goal of this study is to assess the factors that affect participation of population at average risk in colorectal cancer screening programs, based on health belief model structures.
  
  
  METHODS
  A cross-sectional survey of 196 individuals, more than 50 years old, was conducted in Isfahan. Ninety-eight people of the target group were selected from laboratories while they came there for doing FOBT test; the method of sampling in this group was random sampling. The method of data collection in the other 98 individuals was by home interview and they were selected by cluster sampling. The questionnaire used was based on health belief model to assess the factors associated with performing FOBT. The data collected were analyzed using descriptive and inferential statistical methods.
  
  
  RESULTS
  The mean score of knowledge in the first group was 48/5 ± 11/7 and in the second group was 36/5 ± 19/3. Individuals in the first group were more likely to be married, had more years of schooling, and better financial status. There were significant relationships between knowledge (P<0.001), perceived susceptibility (P<0.001), perceived severity (P<0.001), perceived barriers (P<0.001), and self-efficacy (P<0.001) in the two groups. There was no significant association between the perceived benefits in the two groups. Those people who have had FOBT test in last year in each group reported better score of Health Belief Model model structures.
  
  
  CONCLUSIONS
  According to this study, it seems that there is an urgent need to pay more attention to this disease and its prevention through screening. With a better understanding of factors affecting the test, it can be a useful step to reduce the rate of death and costs, and improve the community health outcomes.
authors.affiliation: Department of Health Education and Promotion, University of Medical Sciences, Isfahan, Iran.
authors.forename: Seyed Homamodin
authors.initials: SH
authors.lastname: Javadzade
authors.forename: Mahnoosh
authors.initials: M
authors.lastname: Reisi
authors.forename: Firoozeh
authors.initials: F
authors.lastname: Mostafavi
authors.forename: Akbar
authors.initials: A
authors.lastname: Hasanzade
authors.forename: Hossein
authors.initials: H
authors.lastname: Shahnazi
authors.forename: Gholamreza
authors.initials: G
authors.lastname: Sharifirad
keywords: Colorectal cancer; HBM model; fecal occult blood testing
references.citation: Prev Med. 2005 Aug;41(2):676-84
references.pmid: 15917068
references.citation: J Am Board Fam Med. 2008 Sep-Oct;21(5):414-26
references.pmid: 18772296
references.citation: J Cancer Educ. 2008;23(4):241-7
references.pmid: 19058074
references.citation: Cancer Nurs. 2009 Sep-Oct;32(5):412-7
references.pmid: 19661793
references.citation: Int J Cancer. 1995 May 16;61(4):465-9
references.pmid: 7759151
references.citation: Patient Educ Couns. 2009 Aug;76(2):240-7
references.pmid: 19150198
references.citation: Prev Med. 2004 Jul;39(1):56-63
references.pmid: 15207986
references.citation: CMAJ. 2004 Aug 31;171(5):461-5
references.pmid: 15337726
references.citation: Cancer Nurs. 2004 May-Jun;27(3):206-15; quiz 216-7
references.pmid: 15238806
references.citation: Health Expect. 2007 Jun;10(2):148-60
references.pmid: 17524008
references.citation: J Cancer Educ. 2008;23(4):238-40
references.pmid: 19058073
references.citation: Asian Pac J Cancer Prev. 2005 Jul-Sep;6(3):359-63
references.pmid: 16236000
references.citation: Health Place. 2009 Jun;15(2):505-513
references.pmid: 19028134
references.citation: Prev Med. 2004 Aug;39(2):323-9
references.pmid: 15226041
references.citation: Nurs Res. 2009 Sep-Oct;58(5):312-20
references.pmid: 19752671
references.citation: J Womens Health (Larchmt). 2010 Apr;19(4):775-84
references.pmid: 20201702
references.citation: Cancer. 2007 Oct 1;110(7):1578-85
references.pmid: 17696119
references.citation: Am J Health Promot. 2009 Jan-Feb;23(3):168-75
references.pmid: 19149421
references.citation: Arch Intern Med. 2007 Feb 12;167(3):258-64
references.pmid: 17296881
references.citation: Patient Educ Couns. 2009 Jun;75(3):352-7
references.pmid: 19386461
references.citation: Prev Med. 2005 Jul;41(1):23-9
references.pmid: 15916989
references.citation: J Community Health. 2009 Apr;34(2):113-21
references.pmid: 19145482
references.citation: J Community Health. 2009 Apr;34(2):90-7
references.pmid: 18941876
references.citation: Prev Med. 2004 Jun;38(6):669-75
references.pmid: 15193887
references.citation: Ann N Y Acad Sci. 2004 Dec;1031:223-33
references.pmid: 15753148
references.citation: J Cancer Educ. 2008 Jan-Mar;23(1):37-45
references.pmid: 18444045
references.citation: J Womens Health (Larchmt). 2005 May;14(4):324-30
references.pmid: 15916506
references.citation: Prev Med. 2003 Dec;37(6 Pt 1):627-34
references.pmid: 14636796
references.citation: N Engl J Med. 2000 Nov 30;343(22):1603-7
references.pmid: 11096167
references.citation: Am J Public Health. 2003 Aug;93(8):1268-71
references.pmid: 12893609
references.citation: BMJ. 2000 Sep 30;321(7264):805-8
references.pmid: 11009523
references.citation: J Cancer Educ. 2010 Jun;25(2):160-5
references.pmid: 20094829
references.citation: Cancer Epidemiol Biomarkers Prev. 2002 Jun;11(6):529-34
references.pmid: 12050093
references.citation: Public Health. 2003 Nov;117(6):389-95
references.pmid: 14522153
references.citation: J Health Care Poor Underserved. 2007 Nov;18(4 Suppl):146-64
references.pmid: 18065857
references.citation: Prev Med. 2004 Aug;39(2):239-46
references.pmid: 15226031
references.citation: J Community Health. 2009 Apr;34(2):79-89
references.pmid: 19082695
references.citation: J Occup Environ Med. 2003 Aug;45(8):891-8
references.pmid: 12915791
references.citation: Am J Health Promot. 2008 Nov-Dec;23(2):97-100
references.pmid: 19004158
references.citation: Prev Med. 2005 May;40(5):515-26
references.pmid: 15749133
references.citation: ABNF J. 2003 Sep-Oct;14(5):99-103
references.pmid: 14664193
references.citation: N Engl J Med. 1993 Dec 30;329(27):1977-81
references.pmid: 8247072
references.citation: J Cancer Educ. 2006 Summer;21(2):84-8
references.pmid: 17020519
references.citation: J Urban Health. 2007 Jan;84(1):32-44
references.pmid: 17186375
references.citation: Cancer. 2008 Mar 15;112(6):1230-8
references.pmid: 18266204
references.citation: Am J Health Promot. 2006 Jul-Aug;20(6):401-10
references.pmid: 16871820
references.citation: Am J Gastroenterol. 2007 Aug;102(8):1727-35
references.pmid: 17437502
references.citation: Oncol Nurs Forum. 2010 Sep;37(5):581-91
references.pmid: 20797950
references.citation: J Natl Cancer Inst. 1994 Jul 6;86(13):997-1006
references.pmid: 7980765